Cost-Effectiveness Analysis of Bendamustine-Rituximab Treatment Compared with Fludarabine-Rituximab Treatment, in Patients with Indolent Non-Hodgkin’s Lymphoma in Costa Rica
Abstract
Authors
Z. Desanvicente-Celis C.A. Obando M. Chaves L. Gonzalez D. Muschett